Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/386557
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2022-06-15T05:48:59Z-
dc.date.available2022-06-15T05:48:59Z-
dc.identifier.urihttp://hdl.handle.net/10603/386557-
dc.description.abstractLurasidone hydrochloride (LH) suffers from poor aqueous solubility and low oral newlinebioavailability which warrants increase of LH doses causing toxicity to normal tissues. newlineTherefore, the current research focused on curtailing the inherent issues of LH by formulating newlineits nanoparticles (NPs) and their conjugation via transferrin (Tf). Chitosan (CH)-NPs were newlineprepared via ionic gelation technique and then optimized using QbD approach. The optimized newlineNPs were further to Tf conjugation via thiolation technique and further prepared using ionic newlinegelation method. The prepared NPs were analyzed for in vitro drug release and in vivo brain newlinetargeting efficiency. newlineChitosan NPs and Tf-conjugated CH-NPs exhibited mean particle size (154.8±4.5 nm; 207.1± newline5.43 nm), mean polydispersity index (0.433± 34.5; 0.411 ± 0.065); % EE (88.5± 0.05; 87.6 ± newline0.06); and % DLC (8.8±0.07; 7.6 ± 0.054) respectively. Transmission electron microscopy newlineexaminations revealed spherical particle size with uniform drug distribution. Physicochemical newlinestability of CH-NPs conducted for 12 weeks and showed good stability at (25 ± 2 °C/60 ± 5% newlineRH). DSC thermogram indicated the complete dispersion of drug within the nanoparticles newlineattributable to the loss of crystallinity of LH. FTIR spectra of NPs showed existence of Tf at newlineNPs surface confirming the conjugation of Tf. CH-NPs and Tf-conjugated NPs of LH showed newlineabsence of drug characteristics diffraction peaks indicating loss of crystallinity due to newlineentrapment of drug within the NPs. In vitro release studies established supremacy of LH-CHNPs newlineand Tf-conjugated CH-NPs compared to drug suspension (LH-DS) with cumulative drug newlinerelease of 85.83% and 89.34 ± 5.65 at pH 7.4 and 89.93±3.78% and 91.93 ± 5.67 at pH 6.4 newlinerespectively. Ex vivo nasal permeation studies revealed a 2.5-fold and 2.7-fold higher nasal newlinepermeation of LH from CH-NPs and Tf-conjugated CH-NPs formulation respectively newlinecompared to DS. Confocal microscopy evinced deeper permeation of Tf-conjugated CH-NPs newline(25 and#956;m), and CH-NPs (20 and#956;m) through nasal mucosa in contrast
dc.format.extentxviii, 146
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleDevelopment and Characterization of Lurasidone Hydrochloride Intranasal Nanoparticulate Drug Delivery System for Brain Delivery
dc.title.alternative
dc.creator.researcherAnnu
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordPharmacology and Pharmacy
dc.subject.keywordPharmacology and Toxicology
dc.description.note
dc.contributor.guideAli, Javed and Baboota, Sanjula
dc.publisher.placeDelhi
dc.publisher.universityJamia Hamdard University
dc.publisher.institutionDepartment of Pharmaceutics
dc.date.registered2017
dc.date.completed2022
dc.date.awarded2022
dc.format.dimensions
dc.format.accompanyingmaterialDVD
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Department of Pharmaceutics

Files in This Item:
File Description SizeFormat 
01_title.pdf.pdfAttached File53.09 kBAdobe PDFView/Open
02_certificate.pdf.pdf110.84 kBAdobe PDFView/Open
03_preliminary pages.pdf.pdf373.08 kBAdobe PDFView/Open
04_chapter 1.pdf.pdf348.99 kBAdobe PDFView/Open
05_chapter 2.pdf.pdf187.01 kBAdobe PDFView/Open
06_chapter 3.pdf.pdf185.83 kBAdobe PDFView/Open
07_chapter 4.pdf.pdf333.76 kBAdobe PDFView/Open
08_chapter 5.pdf.pdf2.42 MBAdobe PDFView/Open
09_chapter 6.pdf.pdf708.85 kBAdobe PDFView/Open
10_bibliography.pdf169.85 kBAdobe PDFView/Open
11_appendices.pdf.pdf558.92 kBAdobe PDFView/Open
80_recommendation.pdf751.2 kBAdobe PDFView/Open
abstract.pdf.pdf160.46 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: